ISV President’s Message Linda S. Klavinskis, PhD (ISV President, 2024-2025) Professor of Viral Immunology, Department of Infectious Diseases, King’s College London. It is an honour and privilege to serve as President of the ISV, an association that brings together talented scientists from across the globe at all stages of their careers to exchange
A range of humoral related adverse events can occur after treatment of haematological malignancy with chimeric antigen receptor cell therapies. Here the authors characterise the persistence of humoral immunity and response to vaccination after patients receive B cell targeted chimeric antigen...
The U.S. Food and Drug Administration just handed a gift to vaccine skeptics—not because the science is wrong, but because the optics are terrible.Reports that the FDA blocked or delayed studies confirming the safety of COVID-19 and shingles vaccines, based on millions of patient records, is a perfect...
The authors examine the vaccine landscape through two key areas of research and development—expanding target populations, and emerging vaccine technologies—and discuss cross-cutting issues, including the societal value of vaccines, funding and access, and regional manufacturing.
The Paediatrics Society of Ghana (PSG) has convened a regional workshop in Sunyani to arm frontline health workers with advocacy tools to counter rising vaccine misinformation and restore public confidence in immunisation programmes across the Bono, Bono East, and Ahafo regions.
Blog - In an historic moment for regional solidarity and leadership, West African Ministers of Health today pledged their joint commitment to advance the development of, and readiness for, much-needed vaccines against Lassa fever in recognition of the significant threat to regional health security...
Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue working toward this ultimate game-changer for durable control of the HIV epidemic. In this episode,Drs Elizabeth Bukusi, Peter Godfrey-Faussett, and Nina Russell discuss promising advances in the field of HIV vaccine research and how we can prepare for optimal rollout of an eventual HIV vaccine.
Presenters:
Elizabeth Anne Bukusi, MBChB, M.Med (ObGyn), MPH, PhD , PGD (Research Ethics), MBE (Research Ethics), CIP Senior Principal Clinical Research Scientist Center for Microbiology Research KEMRI Research Professor Departments of Global Health and Obstetrics and Gynecology University of Washington, Nairobi, Kenya Seattle, Washington
Peter Godfrey-Faussett, MBBS, FRCP(UK) Science Advisor United Nations Joint Programme on HIV (UNAIDS) Professor of Infectious Diseases and International Health London School of Hygiene and Tropical Medicine London, United Kingdom
Nina Russell, MD Director for TB and HIV Prevention Bill & Melinda Gates Foundation Seattle, Washington
Content is part of a CME-certified educational program that is supported by independent educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare.
Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue working toward this ultimate game-changer for durable control of the HIV epidemic. In this episode, Dr. Susan Buchbinder and Mr. Jontraye Davis discuss what has been learned and built through the past 40 years of HIV vaccine research, including how HIV vaccine scientific advancements and infrastructure were critical to the success of developing a COVID-19 vaccine.
Presenters:
Susan Buchbinder, MD Clinical Professor Departments of Medicine, Epidemiology and Biostatistics University of California, San Francisco Director, Bridge HIV San Francisco Department of Public Health San Francisco, California
Jontraye Davis, MHA, PMD Pro Community Program Manager FHI 360 Adjunct Instructor North Carolina Central University Durham, North Carolina
Special Commentator:
Jerome H. Kim, MD Director General International Vaccine Institute Seoul, South Korea
Content is part of a CME-certified educational program that is supported by independent educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare.
Broad-spectrum vaccines have been proposed as a tool for rapid response to emerging infectious disease threats and are in pre-clinical development. Here, the authors use mathematical modelling to assess the potential impacts of broadly protective sarbecovirus vaccines for a hypothetical “SARS-X”...
A trial has begun in Poland of 45 doctors who spread anti-vaccine claims during the Covid-19 pandemic. If found guilty of disseminating information inconsistent with medical knowledge, they could lose their medical licences. The doctors are part of a group, the Polish Association of Independent Physicians and Scientists (PSNLiN), that actively opposes the use of vaccines. “They signed a letter which falsely presented both the results of research on vaccines and the entire strategy to combat the pandemic,” Paweł Wróblewski, president of the Lower Silesian Medical Chamber, which is overseeing the case, told broadcaster TVN. “The doctors are accused of promoting anti-health attitudes and publicly disseminating information that is inconsistent with current medical knowledge, thereby acting to the detriment of patients and the entire society,” he added.
This year’s World Immunization Week (April 24-30) carries a simple but powerful message: “For every generation, vaccines work.” It is a timely reminder for Kore...
1. CMV and measles: Ubiquitous pediatric infectionsCytomegalovirus (CMV) and measles virus (MV) have historically been considered classical, ubiquitous viral infections, usually acquired in childhood. In each case, humans are the only host, although from an evolutionary perspective, MV is a relative “newcomer”, having jumped species from cattle-to-humans (initially as the related virus, Rinderpest morbillivirus) in the sixth century [1]. In contrast, all CMVs have co-evolved with their respective animal hosts for millions of years, with human CMV showing the greatest similarity to related primate CMVs [2].
Since 2023, Moderna and Korea University have been developing a new mRNA vaccine for hantavirus. The work has been promising so far, but a finished product isn't likely coming any time soon.
Immunisation program collapsed in Bangladesh after Yunus govt changed vaccine procurement system, and now the country is facing a massive measles outbreak | OpIndia News...
Scientists and physicians should advocate to protect the vaccine research infrastructure that has saved an estimated 154 million lives over the past 50 years, according to a new commentary by researchers at Weill Cornell Medicine and the University of Washington.
Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue working toward this ultimate game-changer for durable control of the HIV epidemic. In this episode, Dr. Swati Gupta and Mr. Marc Dixneuf discuss how to broaden global advocacy and increase investment for an HIV vaccine.
Presenters:
Swati Gupta, DrPH, MPH Vice President and Head of Emerging Infectious Diseases and Scientific Strategy International AIDS Vaccine Initiative New York, New York
Marc Dixneuf, PhD Director General AIDES Pantin, France
Special Commentator:
Jonathan Weber, MB, BChir, PhD, FRCP, FRCPath, FMed Sci Dean of the Faculty of Medicine Imperial College London, United Kingdom
Content is part of a CME-certified educational program that is supported by independent educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare.
Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue working toward this ultimate game-changer for durable control of the HIV epidemic. In this first episode, Dr. Linda-Gail Bekker and Ms. Maureen Luba discuss why an HIV vaccine remains the ultimate game-changer to ending the epidemic and the gaps it will address in the expanding HIV prevention landscape.
Presenters:
Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD Chief Operating Officer Desmond Tutu HIV Foundation Deputy Director Desmond Tutu HIV Centre Past President International AIDS Society Faculty of Health Sciences University of Cape Town Cape Town, South Africa
Maureen Luba Africa Region Advocacy Advisor Global Advocacy for HIV Prevention AIDS Vaccine Advocacy Coalition
Content is part of a CME-certified educational program that is supported by independent educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare.
Vaccines provide one of the most reliable defenses against infectious diseases. By stimulating the body’s immune system to recognize and fight off harmful pathogens, they create a protective barrier long before exposure occurs.
People who whistle past the graveyard (of vaccines) to assure themselves the RFK Jr,. won't take away their vaccines are deluding themselves. It's on video!
A greater weight must be placed on vaccine manufacturing and distribution, both in the United States and worldwide, as we saw major imbalances in the world's response to Covid-19 that highlighted gaps in accessibility.
To get content containing either thought or leadership enter:
To get content containing both thought and leadership enter:
To get content containing the expression thought leadership enter:
You can enter several keywords and you can refine them whenever you want. Our suggestion engine uses more signals but entering a few keywords here will rapidly give you great content to curate.